David Kapp
Family Medicine · Perryille, MONPI 1871685545
Payments from drug & device makers
Across 365 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lilly USA, LLC$828
- Boehringer Ingelheim$403
- Novartis$274
- AstraZeneca$266
- Novo Nordisk$245
- plus $2K from 24 others
What the payments were for
- Food & beverage$7,053100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 159 | $3,433 |
| Lilly USA, LLC | 47 | $828 |
| Boehringer Ingelheim | 22 | $403 |
| Novartis | 13 | $274 |
| AstraZeneca | 14 | $266 |
| Novo Nordisk | 13 | $245 |
| Johnson & Johnson | 14 | $203 |
| Amgen | 10 | $175 |
| Exact Sciences | 6 | $135 |
| GSK | 8 | $116 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| Amarin Pharma, Inc. | 5 | $97 |
| Sunovion Pharmaceuticals Inc. | 6 | $82 |
| Merck | 5 | $79 |
| Bayer | 5 | $77 |
| Sumitomo Pharma America, Inc. | 5 | $76 |
| Pfizer | 4 | $63 |
| Paratek Pharmaceuticals, Inc. | 4 | $61 |
| Phathom Pharmaceuticals, Inc. | 4 | $59 |
| Medtronic | 3 | $58 |
| Astellas Pharma US Inc | 3 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $40 |
| Abbott | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Exeltis, USA Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| RGH Enterprises LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Viatris Specialty LLC | 1 | $14 |
How this compares
$7,073 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 118 | $97,658 |
| FarxigaDapagliflozin Propanediol | 109 | $94,639 |
| JardianceEmpagliflozin | 80 | $79,130 |
| OzempicSemaglutide | 48 | $63,842 |
| JanuviaSitagliptin Phosphate | 54 | $43,138 |
| TrulicityDulaglutide | 25 | $40,751 |
| XareltoRivaroxaban | 45 | $33,840 |
| MounjaroTirzepatide | 27 | $28,108 |
| MyrbetriqMirabegron | 53 | $18,564 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 40 | $11,679 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $11,241 |
| Tresiba Flextouch U-100Insulin Degludec | 24 | $10,858 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 46 | $9,035 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,954 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 44 | $6,392 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $266 | $102,593121 claims |
| PfizerEliquis | $63 | $97,658118 claims |
| Boehringer IngelheimJardiance, Synjardy | $403 | $85,33997 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $828 | $68,85952 claims |
| Novo NordiskOzempic | $245 | $63,84248 claims |
| MerckJanuvia | $79 | $43,13854 claims |
| GSKArexvy, Trelegy Ellipta, Shingrix, Anoro Ellipta, Breo Ellipta | $116 | $42,260121 claims |
| Johnson & JohnsonXarelto | $203 | $33,84045 claims |
| Astellas Pharma US IncMyrbetriq | $47 | $18,56453 claims |
| AbbVieSynthroid | $3,433 | $2,45740 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Perryille
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.